Pacira Pharmaceuticals Inc(PCRX)
38.83
Change: -0.49 (▼ -1.26%)
As of Tue 12/20/2022 01:00 PM% Of Value
Growth
Value Per Share
:
:
:
637.70
26.04
23.0800 (as of 19/12/2022)
Fundamentals Data
| Open | 38.54 | Dividend | 35 |
| Close Price | 38.83 | DivYield | 0 % |
| High | 39.48 | Growth | 111.8 M |
| Low | 37.69 | Growth% | 26.04 |
| P/e | -3604.76 | Volume | 467,229.0 |
| P/b | -0.31 | Market Capital | 1.7 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 49.39 (as of 21/12/2022) | 50 Days Moving Average Percentage | -27.194952356425 (as of 21/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 286.6 M | 337.2 M | 421.0 M | 429.6 M | 541.5 M |
| Cap Spending | -19.2 M | -14.5 M | -10.1 M | -37.8 M | -45.8 M |
| Operating Expenses | 223.6 M | 234.5 M | 303.8 M | 265.9 M | 311.3 M |
| Operating Cash Flow | -24.9 M | 15.9 M | 10.4 M | 46.3 M | 89.9 M |
| Free Cash Flow | -1.4 M | 34.3 M | 60.3 M | 39.2 M | 79.8 M |
| Free Cash Flow Per Share | -0.037 | 0.84 | 1.454 | 0.919 | 1.804 |
| Total liabilities | 276.4 M | 290.9 M | 351.9 M | 541.1 M | 1.1 B |
| Total cash | 54.1 M | 132.5 M | 78.2 M | 99.9 M | 585.5 M |
| ROE% | -0.158 | -0.002 | -0.032 | 0.296 | 0.06 |
| Outstanding Shares | 40.7 M | 41.2 M | 42.0 M | 43.8 M | 44.8 M |
| P/E | -29.905 | -3604.76 | -185.02 | 21.871 | 71.246 |
| P/S | 4.446 | 5.034 | 4.841 | 7.408 | 5.523 |
| Revenue USD | 286.6 M | 337.2 M | 421.0 M | 429.6 M | 541.5 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|